Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Hemostemix Inc
V.HEM
Alternate Symbol(s):
HMTXF
Healthcare
Biotechnology
Hemostemix Inc. is a Canada-based clinical-stage biotechnology company. The Company’s principal business is to develop, manufacture and commercialize blood-derived stem cell therapies to treat various diseases. It is an autologous stem cell therapeutics company that holds 91 patents on the derivation of three stem cell lineages from the patient’s blood, including angiogenic cell precursors (ACP...
-01), neuronal cell precursors, and cardiomyocyte cell precursors. ACP-01 is a lead clinical-stage candidate, like NCP-01 and CCP-01, is generated from the patient’s blood. The Company is engaged in providing treatment for ischemia, such as ischemic cardiomyopathy, angina, peripheral arterial disease including critical limb ischemia. The Company’s proprietary technology is a personalized regenerative therapy that is administered to a patient within seven days of the initial blood draw. Its subsidiaries include Kwalata Trading Limited, Hemostemix Ltd., and PreCerv Inc.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSXV:HEM)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
...
Next
(24)
•••
robert345
X
View Profile
View Bullboard History
Post by
robert345
on Jun 08, 2022 11:16am
Hemostemix information regarding intellectual property
Hemostemix Inc. recently announced the settlement of all litigation with aspire Health Service Inc., AJIA Global, LLC and Alan Jacobs, Jed Wood, Randi Wood, Blake Wood, Kyle Makofka, Reginald
...more
(26)
•••
GustheGreek
X
View Profile
View Bullboard History
Post by
GustheGreek
on Jun 08, 2022 9:03am
Strong Buy!
https://www.barchart.com/stocks/quotes/HEM.VN/opinion
Lahontan Gold Announces Filing of Santa Fe Technical Report
posted Nov 29, 2024 9:00am by
Lahontan Gold Corp.
-
|
Lahontan Gold is pleased to announce that the Company has filed on SEDAR+ an independent Technical Report and updated Mineral Resource Estimate ("MRE") titled "Santa Fe Project Technical Report," effective October 9, 2024, and dated November 27, 2024, for Lahontan's Santa Fe Mine gold and silver project, Santa Fe District, Mineral County, Nevada. ...read more
(13)
•••
trade007
X
View Profile
View Bullboard History
Post by
trade007
on Jun 07, 2022 3:20pm
Data audit successfully executed appears manipulation less
Hemostemix have been handed back its intellectual property consisting of all the clinical trial data of ACP-01 which was long unlawfully held by Accudata and Aspire Health Science, the data audit post
...more
(67)
•••
Jon9800
X
View Profile
View Bullboard History
Post by
Jon9800
on Jun 07, 2022 2:37pm
Addition of Rick Groome could benefit $HEM vastly
Mr. Rick Groome, a financial advisor, was recently inducted to the Hemostemix family, according to Smeenk, who stated that Rick facilitates the organization to reach out to a broader base of investors
...more
(13)
•••
trade007
X
View Profile
View Bullboard History
Post by
trade007
on Jun 07, 2022 2:21pm
Hemostemix releases new CEO update, post data audit
Hemostemix a new age biotechnology and stem cell therapy based healthcare firm recently released a CEO update, where Smeenk was heard talking about the due diligence and data audit of the returned
...more
(17)
•••
christiano
X
View Profile
View Bullboard History
Post by
christiano
on Jun 07, 2022 2:19pm
$HMTXF outstanding shares and public float briefing
$HMTXF has successfully offered and issued an aggregate of 68.2 Million to the shareholders globally in terms of outstanding shares, and a total of 19.34 Million shares are available for the general
...more
(17)
•••
christiano
X
View Profile
View Bullboard History
Post by
christiano
on Jun 07, 2022 2:09pm
Intellectual property returned back to the parent company
Hemostemix (HMTXF) had returned the intellectual property and classified data back, which was long overdue from Aspire Health Science and Accudata solutions, the data received was free of manipulation
...more
(67)
•••
Jon9800
X
View Profile
View Bullboard History
Post by
Jon9800
on Jun 07, 2022 2:08pm
CEO Hemostemix emphasized on the increasing volatility of $H
Thomas Smeenk on the latest update stated “for the stem cell space it is the right time to take a bite of the apple” Thomas later said the management board have invested about $4.5 Million in the
...more
(3)
•••
tradeviewww
X
View Profile
View Bullboard History
Post by
tradeviewww
on Jun 07, 2022 2:07pm
$HEM has shown an impeccable growth over price and volume
The stock graph has regained its strength since the past few weeks of massive growth on the stock price of Hemostemix on TSX-V today a rise of almost $0.032. The company is currently trading at
...more
(6)
•••
Tradeconnects
X
View Profile
View Bullboard History
Post by
Tradeconnects
on Jun 07, 2022 1:50pm
$HEM value and volume over TSX-V
Hemostemix, having the ticker symbol of $HEM listed on TSX-Venture, is currently trading at $0.32, followed by the previous closure of $0.34, which offers a 1.50K of trading volume today for free
...more
(7)
•••
TRADERCONNECTS
X
View Profile
View Bullboard History
Post by
TRADERCONNECTS
on Jun 07, 2022 12:30pm
Cheaper shares to buy-in. $HEM
Cheaper shares to buy-in. $HEM is offering a buyout price of $0.32 per share. Watch $AMLH $PQEFF stock performance.
(120)
•••
ENEMENEMYNEMO
X
View Profile
View Bullboard History
Post by
ENEMENEMYNEMO
on Jun 06, 2022 10:25pm
Shorts
Short positions are drying up quickly!
(24)
•••
robert345
X
View Profile
View Bullboard History
Post by
robert345
on Jun 06, 2022 11:41am
$HEM has announced the closing of debentures
Hemostemix has announced that it has closed the previously released non-brokered convertible debenture in accordance with offering $1,000 principle amount of each debenture. https://www.newsfilecorp
...more
(24)
•••
robert345
X
View Profile
View Bullboard History
Post by
robert345
on Jun 06, 2022 11:30am
$HEM new addition to the team
The company has recently published a press release to announce the appointment of Mr. Richard Groome as a special financial advisor to the CEO. https://www.newsfilecorp.com/redirect/BN4MbT0xgB
(147)
•••
RamboOO7
X
View Profile
View Bullboard History
Post by
RamboOO7
on Jun 05, 2022 3:26pm
Still waiting !!! Snoooooooooooooòooozw
Glad i sold.. waiting to rebuy !
Prev
...
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >